SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin informs about press release

16 Jul 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2382.00 6.00 (0.25%)
05-Aug-2026 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.55
Dr. Reddys Labs. 1165.20
Cipla 1450.50
Lupin 2382.00
Zydus Lifesciences 1112.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: